Another study reported that PARK7 is highly expressed in 52.5% of pancreatic neuroendocrine tumors, and its elevated expression is correlated with aggressiveness, disease progression, and reduced survival of patients with pancreatic neuroendocrine tumors [34]. The gene discussed is PARK7; the disease is pancreatic neuroendocrine tumor.